1/2 December 2020
GMP News No. 227
27 August 2002
Answer to the
Since May 2001, a revised EU document with very similar contents has led a quiet existence (and was published on the Internet in October 2001): the "Compilation of Community Procedures on Administrative Collaboration and Harmonisation of Inspections". This compilation of 86 pages contains among others information on:
Content of the Fabricator's/Manufacturer's Batch Certificate for Drug/Medicinal Products Exported to Countries under the Scope of a Mutual Recognition Agreement (MRA)
Procedure for Co-ordinating Foreign and Community Pre-authorisation Inspections during the Assessment of Applications
Especially the description of how to conduct a GMP inspection (see page 15 following) offers a lot of useful information for pharmaceutical manufacturers.
In this document, you can also find the following activity/decision diagram for inspections on the basis of applications under the centralised system.
The topic "complaints" has been examined closely in this document - like in the FDA Investigational Manual. On the one hand in the context of the Rapid Alert System, which is described in the first part of the above document, on the other hand within the description of the conduct of GMP inspections, where it says under point 19:
Complaints and product recall: the system for recording and reviewing
complaints as well as the system for recalling batches of medicinal
products from within and outside the Member States should be examined
during the inspection.
If you would like to download the "Compilation of Community Procedures on Administrative Collaboration and Harmonisation of Inspections", please click here.